Collaborative efforts between healthcare stakeholders are key to improvements in patient outcomes, quality of care and patient experience. We see this in play in our Greater China market, with IHH China and Gleneagles Hospital Hong Kong embarking on new partnerships. The latter also signed a strategic cooperation agreement with China-based healthcare organisation Jiahui Health to deliver a range of healthcare services.
On 10 and 11 August, a team from Gleneagles Hospital Hong Kong led by its CEO Dr Kenneth Tsang, made a special visit to Shanghai to explore new collaborations with IHH China.
During their tour of Parkway Shanghai Hospital, Parkway Gleneagles Medical & Surgical Center, Parkway Hospital People’s Square and other medical centers, the parties engaged in in-depth discussions, diving into the unique features of our China clinical services, current operations, and recent development plans.
Plans are set in motion to explore academic conferences, multi-site physician practices, seamless patient referrals, second opinions, and the usage of FDA-approved drugs and devices between IHH China and Gleneagles Hospital Hong Kong. Indeed, the future looks brighter as our business units join hands to drive success and advancements in healthcare together.
Separately, Gleneagles Hospital Hong Kong and Jiahui Health sealed a strategic cooperation agreement on 21 August in Shenzhen, reaffirming their dedication to delivering exceptional healthcare services.
Under the game-changing partnership, Gleneagles Hospital Hong Kong and Jiahui Health will harness their collective expertise to advance healthcare via a wide range of services. These include teleconsultations, seamless patient referrals, cross-region consultations, medical exchange and training, precise diagnosis and treatment, and streamlined drug application processes.
Related Stories
Gleneagles JPMC Collects 418kg of Waste in Beach Clean-Up Effort
Celebrate our Brunei colleagues for stepping beyond the hospital walls to make a real, measurable impact on the environment.
.png?sfvrsn=36e1af94_1)
Fortis Hospital Bannerghatta Road Successfully Treats Rare Nasal Tumour in Teen
After nearly two years of misdiagnosis, a 14-year-old boy suffering from a rare nasal tumour found a new lease of life at Fortis Hospital Bannerghatta Road.
Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region
IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.
Fortis Charts the Future of Haematology
On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
